(2022) The Role of Atypical Chemokine Receptor D6 (ACKR2) in Physiological and Pathological Conditions; Friend, Foe, or Both? Frontiers in Immunology. p. 22. ISSN 1664-3224

(2022) Xanthohumol: An underestimated, while potent and promising chemotherapeutic agent in cancer treatment. Progress in biophysics and molecular biology. pp. 3-14. ISSN 1873-1732 (Electronic) 0079-6107 (Linking)

(2022) A comprehensive review of chemokine CXC17 (VCC1) in cancer, infection, and inflammation. Cell Biology International. pp. 1557-1570. ISSN 1065-6995